Regulatory / Ethical Submission

Comprehensive support throughout the regulatory and ethical submission process, ensuring compliance with national and international requirements.

Services include:

  • Support in the elaboration and adaptation of study protocols.
  • Preparation and adaptation of the patient information sheet and informed consent form.
  • Compilation of local documentation for the submission dossier.
  • Support in the negotiation and management of site contract agreements.

“Ensure Compliance. Accelerate Approval.”

Clinical Trial Registry

Design and registry of study protocols in ClinicalTrials.gov

“Register Protocols. Build Transparency.”

NIH ClinicalTrials.gov
Protocol ID
Bried Title
CT.gov ID
In-Situ Simulation Evaluating the Impact of In-Situ Simulation on Interprofessional Healthcare Team Training
UZit® The Feasibility, Efficacy and Safety of UZit®: Single-arm Clinical Trial in Patients With Symptomatic Chronic Venous Disease NCT07236307
FABRyCar Novel Diagnostic and Prognostic Predictors in Fabry Cardiomyopathy: Proof of Concept in a Rare Disease
INITIATE-HFrEF Initiation of ARNi and SGLT2i in Patients With HFrEF NCT05989503
MESOMEGA A Multicenter Study to Optimize Microembolic Signal Classification Based on Double-Blind Multiparametric Assessment by Human Experts Using a Universal Graphic Interface NCT07172165
MedMom Mediterranean Diet Intervention for Maternal Postpartum NCT07038681 
ESOA-19 Effectiveness and Safety of New Oral Antivirals for COVID-19 NCT05894603
FAMINT Atrial Fibrillation in Internal Medicine
BLHN/Pediatric Nutrition Determinants of the Nutritional Composition of Donor Human Milk NCT06904924
CALGUT Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome NCT07173062
SOLGADI-PEF Dapagliflozin With or Without Spironolactone for HFpEF NCT05676684
CarothidAtheroScreening Randomized Controlled Trial on Carotid Atherosclerosis Screening in Asymptomatic Smokers and Hypertensive Adults: Prevalence and Impact on Cardiovascular Prevention NCT06848283
Acute Myeloid Leukemia Effectiveness of Early Intervention in Palliative Care for Acute Myeloid Leukemia Patients Comparing to Standard of Care NCT06848270
MASK-air® Early Warning System for Allergic Rhinitis in the MASK-air® App NCT06768736
VBSS Video-based Learning for Basic Surgical Skills NCT06571903
SleePsy Association Between Sleep and Psychomotor Development in Early Childhood NCT06816225
SUNRISE Transcranial Doppler (TCD) Ultrasound and Cognition in Cerebral Vascular Disease. NCT06735274
DemRefImprov Improving the Referral of Patients With Suspected Cognitive Impairment and Early Dementia NCT05890313
LookUp Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib) NCT06498167
Shadow4All Shadow for All, a Citizenship Science Study to Promote the Prevention of Skin Cancer NCT06145464
IoMumNext Environmental Pollutants in Pregnancy NCT06226311
F-CHECK Screening of Fabry Disease in Portuguese Patients With Idiopathic Cardiomyopathies NCT05409846
QualityCPR Influence of Posture and Positioning in Rescuer’s Fatigue and Quality of Chest Compressions NCT05405569
FIBRALUNG Fibrosing ILD Biomarkers That Rule Acceleration NCT05635032
R_ReLoCC Registry of Local Recurrences After Breast-conserving Surgery NCT05406661
PER2022 Pulmonary Embolism Registry NCT05391646
VeggieNutri_2022 Nutritional and Metabolic Status of Vegetarian and Omnivorous Portuguese Adults NCT05408962
TrainCPR Assessment of CPR Skills Acquisition and Retention: Impact of Technology and Self-training NCT05493189
VascLup Microvascular Ocular Changes of Systemic Lupus Erythematous NCT05863689
SMAs Virtual SMAs in Lifestyle Approach for Type 2 Diabetes NCT05279326
CarPoS Systemic Transthyretin Amyloidosis: Carpal Tunnel Syndrome in a Portuguese Population NCT05409833

Electronic Case Report Form (eCRF)

Design and management of electronic data collection systems, including OpenClinica, REDCap and LimeSurvey.

“Digitize Data. Streamline Research.”

Study
Platform
Start
Centres
Users
Enrollment
Sponsor/Financing
Area
R_ReLoCC OpenClinica 2024 27 55 46/300 FMUP Oncology
LOOK-UP OpenClinica 2024 3 18 64/150 FMUP/Infarmed Pharmacovigilance
FAMINT OpenClinica 2024 21 201 1367/500 SPMI Internal Medicine
INITIATE-HFrEF OpenClinica 2024 4 12 62/172 FMUP/Novartis Cardiovascular Diseases
MESOMEGA OpenClinica 2025 FMUP Neurology
Epi-Asthma LimeSurvey 2022 38 FMUP/ICVS/AstraZeneca Respiratory Diseases
BEAMER LimeSurvey 2025 5 Medida/IHI Therapeutic Adherence
Inspirers-HTN LimeSurvey 2025 4 Medida/IHI Therapeutic Adherence

Monitoring Activities

Full monitoring services ensuring quality, traceability, and compliance of clinical trials.

Services include:

  • Preparation of the Investigator’s Site File (ISF).
  • Planning, conduct, and reporting of initiation visits, regular monitoring visits, and close-out visits.
  • Review of monitoring reports and continuous study follow-up.
  • Support in the database lock process.

“Monitor Integrity. Secure Outcomes.”

Pharmacovigilance in Clinical Trials

We provide comprehensive pharmacovigilance support to ensure the highest standards of safety monitoring in clinical research. With the oversight of an EU Qualified Person for Pharmacovigilance (QPPV), our team is dedicated to the early detection, assessment, and prevention of adverse reactions, while guaranteeing compliance with all regulatory obligations.

Key Services:

  • Training pharmacovigilance programmes for investigation teams.
  • Management and reporting of SAEs/SUSARs.
  • SAE reconciliation activities.
  • Systematic literature search and review.
  • Preparation and submission of safety reports.

“Detect Risks. Protect Patients.”

  • Registration of active substances, Development Medicinal Products (DMP), and Authorised Medicinal Products (AMP) using the EudraVigilance Web-based
    application (EVWEB).
  • Medical device safety surveillance (Materiovigilance), including:
    • Training materiovigilance programmes for investigation teams;
    • Monitoring and reporting of all types of adverse events;
    • Preparation and submission of safety reports to competent authorities.
Study
Phase
Start
End
Scope
Enrollment
Sponsor/Financing
CRO
Area
Link
OCD-RT Phase 2 2024 2028 National Recruiting 2CA-Braga 2CA-Braga Mental Disorders NCT06611592
MODAFIMS Phase 2 2024 2026 National Recruiting 2CA-Braga 2CA-Braga Nervous System Diseases NCT06592352
TryptoBPH Phase 2 2024 2026 National Recruiting 2CA-Braga 2CA-Braga Oncology; Male Urogenital Diseases NCT05401032
INITIATE-HFrEF Phase 4 2023 2025 National 62 FMUP/Novartis CRU-RISE Cardiovascular Diseases NCT05989503
MAGNETICAL Phase 4 2024 2025 National Recruiting ULSTMAD 2CA-Braga Cardiovascular Diseases
Study
Phase
Start
End
Scope
Enrollment
Sponsor/Financing
CRO
Area
Link
Hydrustent Pilot 2025 2026 National 134 Hydrumedical 2CA-Braga Urologic Diseases NCT06719089

Translation and Editing Services in Clinical Research

“Communicate Clearly. Ensure Compliance”

This service is available across multiple therapeutic areas and research phases, covering, but not limited to:

  • Study protocols and amendments.
  • Informed consent forms (ICFs).
  • Case report forms (CRFs).
  • Patient-reported outcome (PRO) instruments and quality-of-life questionnaires.
  • Investigator brochures and safety updates.
  • Clinical study reports (CSRs).
  • Regulatory submissions and correspondence with authorities.

Beyond translation, we offer editing services to guarantee that documents are accurate, coherent, and culturally appropriate. This process involves:

  • Copyediting and Proofreading: Improves the text, fixes grammar, punctuation, spelling, and typos.
  • Ensure Consistency: Check for uniformity throughout the document, aligning wording across protocols, consent forms, and reports.
  • Enhance Style: Refine the language and tone to be appropriate for the intended audience and/or publication type and meet professional and regulatory standards.
  • Terminology verification to ensure consistency across all study materials.
  • Readability checks for patient-facing documents, ensuring accessibility and ethical clarity. Make sure sentences and paragraphs logically follow one another, improving readability.

Clear and precise communication is critical for scientific rigor in clinical research and a key component of regulatory compliance and patient safety. It is crucial that all documentation, ranging from complex technical study protocols to patient-facing materials, is precise and culturally appropriate.

Our translation and editing services are designed to meet these critical demands, ensuring that your research adheres to the highest standards. These services are available in:

  • English (UK or USA only).
  • Portuguese (Portugal).
  • Spanish (Spain).
  • Other variants of Portuguese (e.g., Brazil) and Spanish (e.g., variants from Latin America) upon assessment of the requested service

Average services delivery time limits:

  1. Standard (500-800 words/day)
  2. Express (1000-1500 words/day)
  3. Urgent (only for documents with up to 2000 words)

Statistical Services

Statistics

Our team combines expertise and precision to provide statistical solutions tailored to the specific needs of each research project. Every study is unique, and we work to turn data into solid, evidence-based decisions.

Key Services:

  • Support in defining the research protocol.
  • Guidance on selecting data collection technologies.
  • Sample size calculation.
  • Development of the Statistical Analysis Plan.
  • Execution of statistical analyses with detailed technical reporting.
  • Validation and consultancy on conducted data analyses.
  • Methodological review and support in drafting abstracts and scientific articles.

“Decode the Data. Strengthen Decisions.”

Intellectual Property Protection

Intellectual property (IP) is intangible property and can be viewed as the results and outcomes of research. Its commercial value may be realized via various routes including licensing or selling intellectual property rights (IPR). IPRs may be found in Inventions, Software, Materials, Databases, Processes, Research Tools and Creative Works.

Thus, it is important to contact us before sharing your innovation, in order to discuss its full potential and our process, which may lead to requesting protection for your innovation with patents, copyrights, trademarks, or know-how, as applicable, based on its commercial potential.

Our team is in place to offer expertise and guidance for all stages of the process, starting with the discovery, submission of IP disclosure, internal evaluation, IP protection and management, up until the phase of technology transfer.

This support includes:

  • Establishing a strategy for the efficient management of intellectual assets.
  • Clarifying ownership of intellectual assets in joint research.
  • Bridging the gap from intellectual assets creation to the market.

“Safeguard Innovation. Unlock Potential.”